Obana M, Oda T, Matsuoka Y, Irimajiri S, Kano S, Suzuki M
Department of Internal Medicine, Kawasaki Municipal Hospital.
Kansenshogaku Zasshi. 1994 Mar;68(3):399-402. doi: 10.11150/kansenshogakuzasshi1970.68.399.
A 44-year-old male, who had been to Lagos, Nigeria, was admitted to our hospital because of a high grade fever on July 20, 1993. On admission, Plasmodium falciparum was detected in his blood smears and the antibody titers against P. falciparum and Plasmodium vivax antigens were 1:256 and < 1:4 respectively by the indirect fluorescent antibody test. Therefore, he was diagnosed as having P. falciparum malaria. He was treated with halofantrine (Halfan: Smith Kline Beecham Pharmaceuticals, England), two tablets at six-hourly intervals, a total of six tablets (1500 mg). Parasites were cleared rapidly and remission was achieved without any adverse reactions. Halofantrine can therefore be recommended for the treatment of imported P. falciparum malaria.
一名44岁男性,曾前往尼日利亚拉各斯,因高热于1993年7月20日入住我院。入院时,在其血涂片中检测到恶性疟原虫,间接荧光抗体试验显示其针对恶性疟原虫和间日疟原虫抗原的抗体滴度分别为1:256和<1:4。因此,他被诊断为患有恶性疟原虫疟疾。他接受了卤泛群(Halfan:英国史克必成制药公司)治疗,每6小时服用两片,共六片(1500毫克)。寄生虫迅速清除,病情缓解,且无任何不良反应。因此,卤泛群可推荐用于治疗输入性恶性疟原虫疟疾。